<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>CatsWannaBeCats.Com | Cochrane Hartmann | Activity</title>
	<link>https://www.catswannabecats.com/members/tearoast4/activity/</link>
	<atom:link href="https://www.catswannabecats.com/members/tearoast4/activity/feed/" rel="self" type="application/rss+xml" />
	<description>Activity feed for Cochrane Hartmann.</description>
	<lastBuildDate>Mon, 06 Jul 2026 08:03:58 -0400</lastBuildDate>
	<generator>https://buddypress.org/?v=7.2.0</generator>
	<language>en-CA</language>
	<ttl>30</ttl>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>2</sy:updateFrequency>
	
						<item>
				<guid isPermaLink="false">c9267e46a74a41f4d7641dcd9117c953</guid>
				<title>Cochrane Hartmann posted an update: © The Author(s) 2020. Published by Oxford University Press. [&#133;]</title>
				<link>https://www.catswannabecats.com/activity/p/22133/</link>
				<pubDate>Sat, 07 Jun 2025 08:17:19 -0400</pubDate>

									<content:encoded><![CDATA[<p>© The Author(s) 2020. Published by Oxford University Press. All rights reserved. For Permissions, please email <a href="mailto:journals.permissions@oup.com.Neural" rel="nofollow ugc">journals.permissions@oup.com.Neural</a> cell adhesion molecule 2 (NCAM2) is involved in the development and plasticity of the olfactory system. Genetic data have implicated the NCAM2 gene in neurodevelopmental disorders including Down&hellip;<span class="activity-read-more" id="activity-read-more-22133"><a href="https://www.catswannabecats.com/activity/p/22133/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">2e4b77e36c2611dabe3041ecdba8d6f6</guid>
				<title>Cochrane Hartmann posted an update: In a rat liver injury model and a femoral artery injury [&#133;]</title>
				<link>https://www.catswannabecats.com/activity/p/17695/</link>
				<pubDate>Tue, 03 Jun 2025 08:08:33 -0400</pubDate>

									<content:encoded><![CDATA[<p>In a rat liver injury model and a femoral artery injury model, the PACG/CMC sponge can significantly reduce the bleeding time and blood loss compared with gauze and commercial gelatin sponge because of the high blood absorption ability and effective concentration of blood coagulation factors. This PACG sponge holds promising potential as a&hellip;<span class="activity-read-more" id="activity-read-more-17695"><a href="https://www.catswannabecats.com/activity/p/17695/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">6b67b81acd82cc6f23040a384f418126</guid>
				<title>Cochrane Hartmann posted an update: These genes are predictive in relapse-free survival, [&#133;]</title>
				<link>https://www.catswannabecats.com/activity/p/11209/</link>
				<pubDate>Sun, 01 Jun 2025 05:13:06 -0400</pubDate>

									<content:encoded><![CDATA[<p>These genes are predictive in relapse-free survival, indicative of their potential tumor promoting or suppressive functions, respectively. Knockdown of two upregulated genes (DYNLT3 and P4HA3) or overexpression of the downregulated ALX4 significantly reduced breast cancer cell proliferation, migration, and clonogenicity. Moreover, knockdown of&hellip;<span class="activity-read-more" id="activity-read-more-11209"><a href="https://www.catswannabecats.com/activity/p/11209/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">bb5b82005103446fc2aabca9a0fd0145</guid>
				<title>Cochrane Hartmann became a registered member</title>
				<link>https://www.catswannabecats.com/activity/p/11098/</link>
				<pubDate>Sun, 01 Jun 2025 04:37:39 -0400</pubDate>

				
									<slash:comments>0</slash:comments>
				
							</item>
		
	</channel>
</rss>